ECOR electroCore Medical Profit After Tax

Corporate emblem and logo of electroCore, Inc. (ECOR)

The net income level of electroCore, Inc. (ECOR) reflects business dynamics, with the current figure standing at -0.01. Growth for electroCore, Inc. (ECOR) is driven by gammaCore systems for the treatment of PTSD and depression. Patents and strict FDA oversight serve as a moat against competitors. Development stability is guaranteed by the loyalty of specialized engineers, which prevents the loss of critical competencies within the medtech sector.

Net Income: electroCore (ECOR) for 07/04/2022 - 10/29/2026

Financial and market metric breakdowns for electrocore.com (ECOR)

- market value and analyst target forecast:
Stock Price electroCore|ECOR - Price Target Chart
- market capitalization data:
Market Valuation ECOR|ECOR - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share electroCore|ECOR - Company Net Assets|Market Capitalization to Book Value Ratio electrocore.com|ECOR - Cumulative Company Assets
- debt burden and liquidity indicators:
Aggregate Debt to Capital electroCore, Inc.|ECOR - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient electroCore|ECOR - Company Aggregate Debts|Debt to Book Value ECOR|ECOR - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings electroCore|Quick Liquidity Indicator electrocore.com
- company profitability and valuation multiples indicators:
ECOR - Net Profit
Fundamental valuation:ECOR, electroCore Medical
Flagship merchandise of electroCore Medical

Scaling the delivery of gammaCore systems to the US hospital network directly converts operating margin growth into real cash flow for electroCore, Inc. (ECOR). This metric aggregates total income minus all expenses, allowing investors to strip away one-time revaluations and assess the fundamental stability of the business through the company's current net result.

Key competitors

Dexcom CGM (DXCM) - Net Profit|Company Net Income Penumbra, Inc.|novanta.com - Profit After Tax|Net Profit HAE|INSP - Company Net Income|PROCEPT BioRobotics Inc - Net Income|Net Profit CONMED Inc. CNMD|PLSE: Net Income|inmodemd.com - Profit After Payment of Taxes|PMI: Net Profit|SRDX - Net Financial Result|SENS (Senseonics Holdings) - Net Profit|Net Income NeuroPace Medical (NPCE)|Net Income TCMD (Tactile Systems Technology)|SNWV (sanuwave.com) - Final Profit|Company Net Income Outset Medical OM|ELMD - Net Income|LENSAR, Inc - Net Profit|Company Net Income AVITA Medical Inc|PROF: Net Profit|Company Profit BDMD|EDAP (EDAP TMS SA) - Net Profit|Bovie Medical (APYX) - Net Financial Result|Net Profit ICCM|Net Income pulmonx.com LUNG|Net Profit TELA (TELA Bio)|Net Profit CytoSorbents Corp CTSO|SRTS - Company Net Income|ZYXI: Company Net Income|RBOT (vicarioussurgical.com) - Net Income|Inspira Technologies - Final Profit|ICU (SeaStar Medical Holding) - Net Profit|Company Net Income IRIDEX Corp. IRIX|Company Net Income Intelligent Bio Solutions (INBS)|beyondair.net (XAIR) - Annual Net Income|Profusa, Inc. - Net Income|Net Profit STRATA Skin Sciences Inc. SSKN|GlucoTrack - Net Profit|Net Financial Result NanoVibronix Inc. NAOV|Venus Concept (VERO) - Company Net Income|Profit After Tax NUWE (Nuwellis Inc)|Company Net Income Aethlon|Net Income TransEnterix (ASXC)|Net Profit AVGR|BSGM - Company Net Income|Company Net Income Cutera CUTR|KNW: Company Profit|NARI: Net Income|Nevro Medical - Profit After Payment of Taxes|RSLS: Net Profit|Company Net Income silkroadmed.com (SILK)